On January 13, when rumors of Wuhan flu COVID-19 began to circulate, the French government took the bizarre, inexplicable, unprecedented, and highly suspicious step of reassigning HCQ from an over-the-counter to a prescription medicine.43 Without citing any studies, French health officials quietly changed the status of HCQ to “List II poisonous substance” and banned its over-the-counter sales.44
